Session R.A. II (CIK 0001701846)

Latest company ownership

Shares held
9,430,582
Last filed at
Sep 23, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jul 12, 2023 Jul 14, 2023 Taysha Gene Therapies, Inc. 10% Owner Sell 32.5 -85,872 -0.93% $60.8K
Jun 22, 2023 Jun 26, 2023 Taysha Gene Therapies, Inc. 10% Owner Sell 43.8 -28,608 -0.31% $20.1K
Jun 20, 2023 Jun 22, 2023 Taysha Gene Therapies, Inc. 10% Owner Sell 20.0 -434,615 -4.48% $307.8K
Nov 23, 2021 Dec 8, 2021 Taysha Gene Therapies, Inc. CEO Buy 67.5 +42,518 0.45% $529.1K